Benzinga | Mar 9, 2021 05:23AM EST

Ardelyx Awarded U.S. Patent 10,940,146 'NHE3-binding compounds and methods for inhibiting phosphate transport'

Provided are NHE3-binding and/or NHE3-modulating agents having activity as phosphate transport inhibitors, including inhibitors of phosphate transport in the gastrointestinal tract and the kidneys, and methods for their use as therapeutic or prophylactic agent.